Bone cancer rehab: will patients follow their home workouts?
NCT ID NCT05779670
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how well bone cancer patients follow a personalized home exercise program in the first six months after lower leg surgery. Researchers will track daily exercise logs from 50 patients and explore what factors help or hinder adherence. The goal is to learn how to better support recovery, not to test a new drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- personalized home exercise program
- What this could lead to
- If successful, this could help design better rehab programs that patients are more likely to follow, improving recovery after bone cancer surgery.
- What could go wrong
- This is a small, observational study with only 50 participants. It does not test a new treatment, so it cannot directly improve outcomes—only identify patterns.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Will be recruited consecutively all patients with bone cancer undergoing resection and reconstruction of the lower limb at the "Orthopedic and Traumatological Clinic III to prevalent oncological address" of the Rizzoli Orthopaedic Institute in the period from 01/2023 to 12/2024 and subsequently to the "SC Osteoncologia, sarcomas of bone and soft tissues, and innovative therapies of the same hospital for the continuation of treatment" in the next six months after surgery.
- Ages
-
12 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients aged 12 years with bone tumor undergoing surgery (resection and reconstruction of the lower limb) and in adjuvant treatment * patients under physiotherapy treatment Exclusion Criteria: * patients with difficulties in understanding the Italian language * patients not using digital services
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bone tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Istituto Ortopedico Rizzoli
RECRUITINGBologna, 40136, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A vast data bank could unlock secrets of bone and muscle diseases
- Can an immune booster outsmart High-Risk bone cancer?
- Can a new drug tame ewing sarcoma when others fail?
- Can an antibody drug outsmart resistant Ewing's sarcoma?
- Can a new tracer light up bone cancer tumors?
- Can a Two-Drug combo beat tough childhood cancers?